Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Experience of Elagolix For the Treatment of Endometriosis in Canada: An Observational Cohort Study (GRACE)

NCT04080856 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04080856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04080856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Experience of Elagolix For the Treatment of Endometriosis in Canada: An Observational Cohort Study (GRACE)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
December 4, 2019
Completion date
September 27, 2021
Enrollment
100 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis